Cancer Research
| Index Medicus: Cancer Res | # of Articles: 60 |
Articles
| Deletion within the D17S34 locus in a primitive neuroectodermal tumor | ||||
| Haataja L, Ledbetter DH, Tanigami A, Petersen D, Heisterkamp N, and Groffen J | ||||
| Yr:1997 | Vol:57 | Nbr: 1 | Pgs: 32-34 | |
| Associated Grant: Two candidate breast cancer genes on chromosome | ||||
| Retinyl methyl ether down-regulates AP-1 transcriptional activation in breast cancer cells | ||||
| Agadir A, Shealy YF, Hill DL, and Zhang X-K | ||||
| Yr:1997 | Vol:57 | Nbr:16 | Pgs: 3444-50 | |
| Associated Grant: Breast Cancer Chemoprevention by Retinoids | ||||
| Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells | ||||
| Agadir A, Shealy YF, Hill DL, Zhang X | ||||
| Yr:1997 | Vol:57 | Nbr: 16 | Pgs: 3444-50 | |
| Associated Grant: Anti-breast cancer activity of vitamin A derivatives | ||||
| Apoptosis induction and potent anti-Er negative breast cancer activity in vivo by a retinoid antagonist | ||||
| Fanjul AN, Piedrafita FJ, Al-Shamma H, and Pfahl M | ||||
| Yr:1998 | Vol:58 | Nbr:20 | Pgs: 4607-4610 | |
| Associated Grant: Novel retinoids that induce apoptosis in breast cancer cells | ||||
| Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normaltissues and tumor cell lines | ||||
| Takayama S, Krajewski S, Krajewska M, Kitada S, aand Zapata JM, et al | ||||
| Yr:1998 | Vol:58 | Nbr:14 | Pgs: 3116-3131 | |
| Associated Grant: TRAF-regulated Signal Transduction in Breast Cancer | ||||
| Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants | ||||
| Burow ME, Weldon CB, Tang Y, Navar G, Hammond T, Krajewski S, and Reed JC, et al | ||||
| Yr:1998 | Vol: 58 | Nbr:21 | Pgs: 4940-4946 | |
| Associated Grant: Immune responses to breast cancers: function of TRAF protein | ||||
| Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7 | ||||
| Piche A, Grim J, Rancourt C, Gomez-Navarro J, ReedJC, and Curiel DT | ||||
| Yr:1998 | Vol:58 | Nbr:10 | Pgs: 2134-2140 | |
| Associated Grant: Bax gene expression in breast cancer | ||||
| DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors | ||||
| Chen Y, Hu D, Eling DJ, Robbins J and Kipps TJ | ||||
| Yr:1998 | Vol:58 | Nbr:9 | Pgs: 1965-71 | |
| Associated Grant: Peptide Vaccines for Immunoprevention of Breast Cancer | ||||
| Cytochrome P450c17a Gene (CYP17)Polymorphism Is Associated with Serum Estrogen and Progesterone Concentrations | ||||
| Feigelson HS, Shames SS, Pike MC, et.al | ||||
| Yr:1998 | Vol:58 | Nbr: | Pgs: 585-587 | |
| Associated Grant: Genetic Susceptibility to Breast Cancer | ||||
| Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2 | ||||
| Deryugina EI, Bourdon MA, Reisfeld RA, and Strongin A | ||||
| Yr:1998 | Vol:58 | Nbr:16 | Pgs: 3743-3750 | |
| Associated Grant: How are Collagenses Involved in Breast Cancer Metastasis? | ||||
| Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy | ||||
| Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM, et al. | ||||
| Yr:1999 | Vol:59 | Nbr:16 | Pgs: 3908-10 | |
| Associated Grant: Multi-ethnic Study of Genetic Control of Plasma Hormones | ||||
| A Single Targeted Ets2 Allele Restricts Development of Mammary Tumors in Transgenic Mice | ||||
| Neznanov N, Man A, Yamamoto H, Hauser C, Cardiff RD, and Oshima RG | ||||
| Yr:1999 | Vol:59 | Nbr:17 | Pgs: 4242-4246 | |
| Associated Grant: Oncogene Regulation in Mammary Cancer | ||||
| Indole-3-carbinol and Tamoxifen Cooperate to Arrest the Cell Cycle of MCF-7 Human Breast Cancer Cells | ||||
| Cover CM, Hsieh SJ, Cram EJ, Hong C, Riby JE, Beljanes LF, and Firestone GL | ||||
| Yr:1999 | Vol:59 | Nbr: | Pgs: 1244-1251 | |
| Associated Grant: Dietary Indole Inhibition of Breast Cancer | ||||
| Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers | ||||
| Gil, J., Yamamoto, H., Zapata, J.M., Reed, J.C. and Perucho M. | ||||
| Yr:1999 | Vol:59 | Nbr:9 | Pgs: 2034-2037 | |
| Associated Grant: TRAF-regulated Signal Transduction in Breast Cancer | ||||
| A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues | ||||
| Yanagisawa J, Ando J, Nakayama J, Kohwi Y, and Kohwi-Shigematsu T | ||||
| Yr:1996 | Vol:56 | Nbr: | Pgs: 457-462 | |
| Associated Grant: The Role of MAR-Binding Protein in Breast Cancer | ||||
| A single targeted Ets allele restricts development of mammary tumors in transgenic mice. | ||||
| Neznanov N, Man AK, Yamamoto H, Hauser CA, Cardiff RD, and oshima RG | ||||
| Yr:1999 | Vol:59 | Nbr:17 | Pgs: 4242-4246 | |
| Associated Grant: Alteration of Developmental Genes in Breast Cancer | ||||
| Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells | ||||
| Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP | ||||
| Yr:2000 | Vol:60 | Nbr:10 | Pgs: 2548-8 | |
| Associated Grant: Galectin-4 As a New Marker for Breast Cancer | ||||
| Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells | ||||
| Eliaz RE and Szoka FC | ||||
| Yr:2001 | Vol:61 | Nbr: | Pgs: 2592-2601 | |
| Associated Grant: Targeted Chemotherapy to Treat Breast Cancer | ||||
| Crkl enhances leukemogenesis in BCR/ABL P190 trangenic mice | ||||
| Hemmeryckx B, van Wojk A, Reichert A, Kaartinen V, de Jong R, Pattengale, et al. | ||||
| Yr:2001 | Vol:61 | Nbr:4 | Pgs: 1398-1405 | |
| Associated Grant: TGF-B3 and small GTPases in Invasive Breast Cancer | ||||
| PDZKI and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. | ||||
| Ghosh MG, Thompson DA, and Weigel RJ | ||||
| Yr:2000 | Vol:60 | Nbr:22 | Pgs: 6367-6375 | |
| Associated Grant: Characterization of hAG-2 and Its Role in Breast Cancer | ||||
| A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast | ||||
| Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Campisi J, Desprez P-Y et.al. | ||||
| Yr:2000 | Vol:60 | Nbr: | Pgs: 1332-1340 | |
| Associated Grant: Targeted search for new transcription factors in breast cell | ||||
| Tissue structure, nuclear organization and gene expression in normal and malignant breast | ||||
| Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, and Schmeichel KL | ||||
| Yr:1999 | Vol:59 | Nbr:7 Suppl | Pgs: 1757-1764s | |
| Associated Grant: Vitamin D and Breast Cancer Prevention: Cell Death vs Growth | ||||
| An intact overexpressed E-cadherin/alph, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma | ||||
| Tomlinson JS, Alpaugh ML, and Barsky SH | ||||
| Yr:2001 | Vol:61 | Nbr:13 | Pgs: 5231-5241 | |
| Associated Grant: Anti-E-Cadherin Apoptosis of Inflammatory Breast Carcinoma | ||||
| Transgenic Polyoma middle-T mice model premalignant mammary disease | ||||
| Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, et al. | ||||
| Yr:2001 | Vol:61 | Nbr:22 | Pgs: 8298-305 | |
| Associated Grant: Nitric Oxide and Arginine in Normal and Tumorous Breast | ||||
| Unique anti-activator protein-1 activity of retinoic acid receptor B1 | ||||
| Lin F, Xiao D, Kolluri SK, Zhang X. | ||||
| Yr:2000 | Vol:60 | Nbr:12 | Pgs: 3271-80 | |
| Associated Grant: Breast Cancer Chemoprevention by Retinoids | ||||
| A polymorphism in CYP17 gene increases the risk of breast cancer | ||||
| Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE | ||||
| Yr:1997 | Vol:57 | Nbr:6 | Pgs: 1063-5 | |
| Associated Grant: Multi-ethnic Study of Genetic Control of Plasma Hormones | ||||
| A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells | ||||
| Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, et al | ||||
| Yr:2000 | Vol:60 | Nbr:5 | Pgs: 1332-1340 | |
| Associated Grant: The Invasive Nature of Epithelial Breast Cancer Cells | ||||
| Id-1, ITF-2 and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation and apoptosis. Journal of Bio;ogical Chemistry, 276, 39213-39219 (2001). | ||||
| S.Parrinello, C.Q.Lin, K.Murata, Y.Itahana, J.Singh, A.Krtolica, J.Campisi, P.Y.Desprez | ||||
| Yr:2000 | Vol:60 | Nbr:5 | Pgs: 1332-40 | |
| Associated Grant: The Invasive Nature of Epithelial Breast Cancer Cells | ||||
| A novel human xenograft model of inflammatory breast cancer | ||||
| Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH | ||||
| Yr:1999 | Vol:59 | Nbr:20 | Pgs: 5079-84 | |
| Associated Grant: A New Model for Inflammatory Breast Carcinoma | ||||
| An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma | ||||
| Tomlinson JS, Alpaugh ML, Barsky SH | ||||
| Yr:2001 | Vol:61 | Nbr:13 | Pgs: 5231-41 | |
| Associated Grant: A New Model for Inflammatory Breast Carcinoma | ||||
| A Role for Dystroglycan in Epithelial Polarization: Loss of Function in Breast Tumor Cells | ||||
| Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ | ||||
| Yr:2002 | Vol:62 | Nbr:23 | Pgs: 7102-7109 | |
| Associated Grant: Tumor Suppression by Dystroglycan in Breast Epithelial Cells | ||||
| Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells. | ||||
| Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, Marks JD, Park JW | ||||
| Yr:2003 | Vol:63 | Nbr:12 | Pgs: 3154-3161 | |
| Associated Grant: Enhanced HER-2 Directed Liposomal Therapeutics | ||||
| Expression of estrogen receptor beta messenger RNA variant in breast cancer. | ||||
| Vladusic EA, Hornby AE, Guerra-Vladusic FK, and Lupu R | ||||
| Yr:1998 | Vol:58 | Nbr: | Pgs: 210-214 | |
| Associated Grant: The Role of a Novel Estrogen Receptor in Breast Cancer | ||||
| Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients | ||||
| Taback B, Giuliano AE, Hansen NM, Singer FR, Shu S, Hoon DS | ||||
| Yr:2003 | Vol:63 | Nbr:8 | Pgs: 1884-7 | |
| Associated Grant: Clinical Utility of Breast Cancer DNA Markers in Serum | ||||
| Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer | ||||
| Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S, Press MF | ||||
| Yr:2001 | Vol:61 | Nbr:7 | Pgs: 3212-9 | |
| Associated Grant: NCCC Breast Cancer Research Training Program | ||||
| Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells | ||||
| James SY, Lin F, Kolluri SK, Dawson MI, Zhang XK | ||||
| Yr:2003 | Vol:63 | Nbr:13 | Pgs: 3531-8 | |
| Associated Grant: Protein Factor PPARg & Vitamin A Compounds in Breast Cancer | ||||
| Enhanced tumor suppression by a p14ARF/p53 bicistronic adenovirus through increased p53 protein translation and stability. | ||||
| Huang Y, Tyler T, Saadatmandi N, Lee C, Borgstrom P, Gjerset RA | ||||
| Yr:2003 | Vol:63 | Nbr: | Pgs: 3646-3653 | |
| Associated Grant: Role of p14ARF in Metastatic Breast Cancer | ||||
| Suppression of Estrogen Biosynthesis by Procyanidin Dimers in Red Wine and Grape Seeds | ||||
| Eng ET, Ye J, Williams D, Phung, S, et al | ||||
| Yr:2003 | Vol:63 | Nbr: | Pgs: 8516-8522 | |
| Associated Grant: Breast Cancer Prevention with Phytoestrogens in Grape Juice | ||||
| Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. | ||||
| Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, Bennington JL, Desprez PY | ||||
| Yr:2003 | Vol:63 | Nbr:21 | Pgs: 7098-7105 | |
| Associated Grant: Role of Id-2 in Breast Cancer and its Relationship to Id-1 | ||||
| Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins. | ||||
| Sumida T, Itahana Y, Hamakawa H, Desprez PY | ||||
| Yr:2004 | Vol:64 | Nbr:21 | Pgs: 7886-7892 | |
| Associated Grant: Role of Id-2 in Breast Cancer and its Relationship to Id-1 | ||||
| Tea intake, COMT genotype, and breast cancer in Asian-American women. | ||||
| Wu AH, Tseng CC, Van Den Berg D, Yu MC | ||||
| Yr:2003 | Vol:63 | Nbr:21 | Pgs: 7526-7529 | |
| Associated Grant: Estrogen metabolizing genes, soy and breast cancer in Asians | ||||
| Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. | ||||
| Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, Marks JD, Park JW | ||||
| Yr:2003 | Vol:63 | Nbr:12 | Pgs: 3154-61 | |
| Associated Grant: Enhanced HER-2 Directed Liposomal Therapeutics | ||||
| Angiogenic acceleration of Neu induced mammary tumor progression and metastasis. | ||||
| Oshima RG, et al Muller WJ, Hauser CA, Cardiff RD | ||||
| Yr:2004 | Vol:64 | Nbr:1 | Pgs: 169-79 | |
| Associated Grant: A Vascular Restriction of Mammary Tumor Progression | ||||
| Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. | ||||
| Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW | ||||
| Yr:2005 | Vol:65 | Nbr:24 | Pgs: 11631-8 | |
| Associated Grant: Enhanced HER-2 Directed Liposomal Therapeutics | ||||
| Estrogen induces lung metastasis through a host compartment-specific response. | ||||
| Banka CL, Lund CV, Nguyen MT, Pakchoian AJ, Mueller BM, Eliceiri BP. | ||||
| Yr:2006 | Vol:66 | Nbr:7 | Pgs: 3667-72 | |
| Associated Grant: Novel Approach to Analyze Estrogen Action in Breast Cancer | ||||
| Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. | ||||
| Kijima, I., Phung, S., Hur, G., Kwok, S.-L. and Chen, S. | ||||
| Yr:2006 | Vol:66 | Nbr: | Pgs: 5960-7 | |
| Associated Grant: Breast Cancer Prevention with Phytoestrogens in Grape Juice | ||||
| Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus) | ||||
| Chen, S., Oh, S.-R., Phung, S., Hur, G., Ye, J.-J., Kwok, S.L., Shrode, G.E., et al. | ||||
| Yr:2006 | Vol:66 | Nbr: | Pgs: 12026-34 | |
| Associated Grant: Breast Cancer Prevention with Phytochemicals in Mushrooms | ||||
| RIN1 is a Breast Tumor Suppressor Gene. Cancer Research. 2007 Dec. 15:67 (24): 11510-6. | ||||
| Milstein M, Mooser CK, Hu H, Fejzo M, Slamon D, Goodglick L, Dry S, Colicelli J | ||||
| Yr:2007 | Vol:67 | Nbr:24 | Pgs: 11510-6 | |
| Associated Grant: Evaluating the Role of the RIN1 Gene in Breast Cancer | ||||
| Adaptation of energy metabolism in breast cancer brain metastases. | ||||
| Chen EI, et al, Yates JR 3rd, and Felding-Habermann B | ||||
| Yr:2007 | Vol:67 | Nbr:4 | Pgs: 1472-86 | |
| Associated Grant: Stem Cells in Breast Cancer Metastasis | ||||
| p38 regulates COX-2 in human mammary epithelial cells and is activated in pre-malignant tissue. | ||||
| Gauthier, M.L., Pickering, C.R., Miller, C. J., Chew, K.L., Fordyce, C.A., et al. | ||||
| Yr:2005 | Vol:65 | Nbr: | Pgs: 1793-9 | |
| Associated Grant: Early Transitions in Breast Cancer | ||||
| Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. | ||||
| Liu J, et al, and Zhang XK, Zeng JZ | ||||
| Yr:2008 | Vol:68 | Nbr:21 | Pgs: 8871-80 | |
| Associated Grant: Nur77-derived Peptides as a Novel Breast Cancer Therapy | ||||
| CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression. | ||||
| Adler AS, Littlepage LE, Lin M, Kawahara TL, Wong DJ, Werb Z, Chang HY | ||||
| Yr:2008 | Vol:68 | Nbr:2 | Pgs: 506-15 | |
| Associated Grant: MYC and CSN5 in the Breast Cancer "Wound Signature" Profile | ||||
| Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. | ||||
| Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, Davis RW, Goodson WH | ||||
| Yr:2008 | Vol:68 | Nbr:7 | Pgs: 2076-80 | |
| Associated Grant: A Novel Biological Framework for the Role of Xenoestrogens | ||||
| Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine Resistance | ||||
| Wong C and Chen S | ||||
| Yr:2009 | Vol:69 | Nbr:22 | Pgs: 8670-7 | |
| Associated Grant: Mechanisms of HSP90 Inhibitor Action in Breast Cancer | ||||
| Missense mutations at threonine 169 of Bax, a hot spot in gastrointestinal cancer, inhibit its apoptotic activity. | ||||
| Gil J, Yamamoto H, Zapata JM, Reed JC, and Perucho M. | ||||
| Yr:1999 | Vol:59 | Nbr: | Pgs: 2034-2037 | |
| Associated Grant: TRAF-regulated Signal Transduction in Breast Cancer | ||||
| Adaptation of energy metabolism in breast cancer brain metastases. | ||||
| Chen EI, et al, and Felding-Habermann B | ||||
| Yr:2007 | Vol:67 | Nbr:4 | Pgs: 1472-86 | |
| Associated Grant: Inhibition of Brain Metastases in Breast Cancer | ||||
| Revealing targeted therapy for human cancer by gene module maps. | ||||
| Wong DJ, Nuyten DS, Regev A, Lin M, Adler AS, Segal E, van de Vijver MJ, Chang HY | ||||
| Yr:2008 | Vol:68 | Nbr:2 | Pgs: 369-78 | |
| Associated Grant: MYC and CSN5 in the Breast Cancer "Wound Signature" Profile | ||||
| Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. | ||||
| Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, Mueller BM, Ruf W | ||||
| Yr:2009 | Vol:68 | Nbr:17 | Pgs: 7219-27 | |
| Associated Grant: Targeting Tissue Factor in Breast Cancer | ||||
| Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. | ||||
| Cao F, Li Z, Lee A, Liu Z, Chen K, Wang H, Cai W, Chen X, Wu JC | ||||
| Yr:2009 | Vol:69 | Nbr:7 | Pgs: 2709-13 | |
| Associated Grant: Imaging of Novel Stem Cell Therapy Targeting Breast Cancer | ||||
| SLITs suppress tumor growth and microenvironment in vivo by silencing Sdf1/Cxcr4 within breast epithelium | ||||
| Marlow, R., Strickland, P., Lee, J., Wu, X., PeBenito, M., Binnewies, M. Le, E., et al. | ||||
| Yr:2008 | Vol:68 | Nbr: | Pgs: 7819-7827 | |
| Associated Grant: Axon Guidance Proteins in Mammary Gland Development | ||||
